Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Body Roundness Index Is Better Correlated with Insulin Sensitivity than Body Shape Index in Young and Middle-Aged Japanese Persons.
Murai N, Saito N, Oka R, Nii S, Nishikawa H, Suzuki A, Kodama E, Iida T, Mikura K, Imai H, Hashizume M, Tadokoro R, Sugisawa C, Iizaka T, Otsuka F, Ishibashi S, Nagasaka S. Murai N, et al. Among authors: nishikawa h. Metab Syndr Relat Disord. 2024 Mar;22(2):151-159. doi: 10.1089/met.2023.0175. Epub 2024 Jan 9. Metab Syndr Relat Disord. 2024. PMID: 38190317 Free PMC article.
Secondary Hypogonadism due to Excessive Ingestion of Isoflavone in a Man.
Imai H, Nishikawa H, Suzuki A, Kodama E, Iida T, Mikura K, Hashizume M, Kigawa Y, Tadokoro R, Sugisawa C, Endo K, Iizaka T, Otsuka F, Nagasaka S. Imai H, et al. Among authors: nishikawa h. Intern Med. 2022 Oct 1;61(19):2899-2903. doi: 10.2169/internalmedicine.8578-21. Epub 2022 Feb 26. Intern Med. 2022. PMID: 35228414 Free PMC article.
Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab-Treated HCC.
Matono T, Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tanaka K, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Aoki T, Kuroda H, Yata Y, Nakamura Y, Yoshida O, Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M; Real‐life Practice Experts for HCC (RELPEC) Study Group; Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. Matono T, et al. Among authors: nishikawa h. J Gastroenterol Hepatol. 2025 Jan 22. doi: 10.1111/jgh.16884. Online ahead of print. J Gastroenterol Hepatol. 2025. PMID: 39844393
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma.
Naganuma A, Kakizaki S, Hiraoka A, Tada T, Hatanaka T, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Hirooka M, Yata Y, Ohama H, Kuroda H, Matono T, Aoki T, Kanayama Y, Tanaka K, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M, Kumada T. Naganuma A, et al. Among authors: nishikawa h. Cancer Med. 2025 Jan;14(2):e70618. doi: 10.1002/cam4.70618. Cancer Med. 2025. PMID: 39840727 Free PMC article.
Association of respiratory infections with the incidence and treatment efficacy in Kawasaki disease.
Hachisuka S, Kitano T, Kitagawa D, Murata M, Onishi M, Mori T, Okubo T, Yamamoto N, Nishikawa H, Onaka M, Suzuki R, Sekine M, Suzuki S, Nakamura F, Yoshida S. Hachisuka S, et al. Among authors: nishikawa h. Diagn Microbiol Infect Dis. 2025 Jan 13;111(3):116688. doi: 10.1016/j.diagmicrobio.2025.116688. Online ahead of print. Diagn Microbiol Infect Dis. 2025. PMID: 39832478
Novel gel-immersion endoscopic injection sclerotherapy method for prophylactic hemostasis of esophageal varices: A pilot feasibility and safety study (with video).
Sugawara N, Iwatsubo T, Mori Y, Takayama K, Sasaki S, Nakajima N, Tanaka H, Hakoda A, Harada S, Ota K, Takeuchi T, Nishikawa H. Sugawara N, et al. Among authors: nishikawa h. DEN Open. 2025 Jan 13;5(1):e70056. doi: 10.1002/deo2.70056. eCollection 2025 Apr. DEN Open. 2025. PMID: 39807430 Free PMC article.
Reinventing type 2 immunity in cancer.
Wagner M, Nishikawa H, Koyasu S. Wagner M, et al. Among authors: nishikawa h. Nature. 2025 Jan;637(8045):296-303. doi: 10.1038/s41586-024-08194-2. Epub 2025 Jan 8. Nature. 2025. PMID: 39780006 Review.
1,602 results